Literature DB >> 24103900

Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Insa Feinkohl1, Phyu Phyu Aung, Marketa Keller, Christine M Robertson, Joanne R Morling, Stela McLachlan, Ian J Deary, Brian M Frier, Mark W J Strachan, Jackie F Price.   

Abstract

OBJECTIVE: People with type 2 diabetes are at increased risk of age-related cognitive decline and dementia. Hypoglycemia is a candidate risk factor, but the direction of association between episodes of severe hypoglycemia and cognitive decline in type 2 diabetes remains uncertain. RESEARCH DESIGN AND METHODS: In the Edinburgh Type 2 Diabetes Study, cognitive function was assessed in 831 adults with type 2 diabetes (aged 60-75 years) at baseline and after 4 years. Scores on seven neuropsychological tests were combined into a standardized general ability factor g. Self-reported history of severe hypoglycemia at baseline (history of hypoglycemia) and at follow-up (incident hypoglycemia) was recorded.
RESULTS: A history of hypoglycemia was reported by 9.3% of subjects, and 10.2% reported incident hypoglycemia. Incident hypoglycemia was associated with poorer cognitive ability at baseline (age- and sex-adjusted odds ratio for lowest tertile of g 2.04 [95% CI 1.25-3.31], P = 0.004). Both history of hypoglycemia and incident hypoglycemia were also associated with greater cognitive decline during follow-up (mean follow-up g adjusted for age, sex, and baseline g -0.25 vs. 0.03 [P = 0.02] and -0.28 vs. 0.04 [P = 0.01], respectively), including after addition of vascular risk factors and cardiovascular and microvascular disease to the models (-0.23 vs. 0.03 [P = 0.04] and -0.21 vs. 0.05 [P = 0.03], respectively).
CONCLUSIONS: The relationship between cognitive impairment and hypoglycemia appeared complex, with severe hypoglycemia associated with both poorer initial cognitive ability and accelerated cognitive decline.

Entities:  

Mesh:

Year:  2013        PMID: 24103900     DOI: 10.2337/dc13-1384

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  61 in total

Review 1.  Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.

Authors:  A H Abdelhafiz; A J Sinclair
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

3.  Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014.

Authors:  Grace K Mahoney; Henry J Henk; Rozalina G McCoy
Journal:  Mayo Clin Proc       Date:  2019-08-15       Impact factor: 7.616

4.  Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Authors:  Malin Nilsson; Nicole Jensen; Michael Gejl; Marianne L Bergmann; Heidi Storgaard; Mette Zander; Kamilla Miskowiak; Jørgen Rungby
Journal:  Diabetologia       Date:  2019-07-31       Impact factor: 10.122

Review 5.  Diabetes and cognition.

Authors:  Elizabeth Rose Mayeda; Rachel A Whitmer; Kristine Yaffe
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

Review 6.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

7.  Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease.

Authors:  Elissa C McIntosh; Daniel A Nation
Journal:  Diabetes Care       Date:  2019-03-04       Impact factor: 19.112

8.  Early detection of cognitive impairment in patients with insulinoma.

Authors:  Hongmei Dai; Hao Chen; Xiafei Hong; Xianlin Han; Qiang Xu; Haiyu Pang; Jing Yuan; Xianze Wang; Peiran Xu; Jialin Jiang; Rui Jiang; Zhe Zhuang; Yupei Zhao; Wenming Wu
Journal:  Endocrine       Date:  2019-07-10       Impact factor: 3.633

9.  Metformin and Sulfonylurea Use and Risk of Incident Dementia.

Authors:  Jeffrey F Scherrer; Joanne Salas; James S Floyd; Susan A Farr; John E Morley; Sascha Dublin
Journal:  Mayo Clin Proc       Date:  2019-08       Impact factor: 7.616

Review 10.  Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.

Authors:  Hiroyuki Umegaki
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.